Concepedia

Ellin Berman

EB

Statistics

Publications

64

Citations

7.2K

H-Index

40

Active since

1983

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

The University of Texas MD Anderson Cancer Center

Cornell University

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Massachusetts General Hospital

Ellin Berman is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and chemotherapy.

Publications per year

1983–2024

64

Publications

64

Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML

Alexander E. Perl, Giovanni Martinelli, Jörge E. Cortes et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts

Aruna Kode, John S. Manavalan, Ioanna Mosialou et al. · Nature · 2014 · 516 citations · Full text

Medicine, Cell Biology, Genetics +10

Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia

Ellin Berman, Glenn Heller, J Santorsa et al. · Blood · 1991 · 369 citations · Full text

Medicine, Hematology, Oncology +11

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Anthony R. Mato, Lindsey E. Roeker, Nicole Lamanna et al. · Blood · 2020 · 318 citations · Full text

Pharmacy, Health Sciences, Internal Medicine +3

Altered Bone and Mineral Metabolism in Patients Receiving Imatinib Mesylate

Ellin Berman, Robert G. Maki, Martin Fleisher et al. · New England Journal of Medicine · 2006 · 317 citations · Full text

Medicine, Endocrinology, Oncology +17

1–5 of 64